Sure, what you say above absolutely makes sense. But also consider following:
Upon appointment at end of Dec 2015, ex CEO and TD both were granted 10 mill share options each vesting upon definition of certain amounts of resources at Lynas Find. Additional options were granted later for Sepeda. Beginning of 2016, total shares in issue after capital raise for Lynas was 87 million. By Oct 2016, CEO and TD each had 6 million options already vested and Lynas was sold by end of 2016.
The current terms place incentive to make new discovery only in reference to 10cent performance hurdle if any. Doesnt BoD want the new CEO to have incentives to make new discovery in Sweden or other Port tenements?
Now we have over 370 million shares and porbably Luso will get millions more. Is getting 2.5 or 5 million shares for Sepeda resolution really an incentive given that legal process can take years to conclude.
Just some food for positive thoughts..
- Forums
- ASX - By Stock
- ERX
- Ann: Managing Director Appointment
Ann: Managing Director Appointment, page-18
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ERX (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ERX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online